Author Correction: Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis

Xiang-Jin Zheng^#^{1

2}, Wen-Lin Chen^#³, Jie Yi⁴, Wan Li^{1

2}, Jin-Yi Liu^{1

2}, Wei-Qi Fu^{1

2}, Li-Wen Ren^{1

2}, Sha Li^{1

2}, Bin-Bin Ge^{1

2}, Yi-Hui Yang^{1

2}, Yi-Zhi Zhang^{1

2}, Hong Yang^{1

2}, Guan-Hua Du^{1

2}, Yu Wang⁵, Jin-Hua Wang^{6

7}

Affiliations

¹ The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, 100050, China.
² Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China.
³ Department of Neurosurgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, China.
⁴ Department of Clinical Laboratory, Peking Union Medical College Hospital, Beijing, 100730, China.
⁵ Department of Neurosurgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, China. ywang@pumch.cn.
⁶ The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, 100050, China. wjh@imm.ac.cn.
⁷ Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China. wjh@imm.ac.cn.

^# Contributed equally.

PMID: 38740905
PMCID: PMC11420235
DOI: 10.1038/s41401-024-01271-2

Published Erratum

Author Correction: Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis

Xiang-Jin Zheng et al. Acta Pharmacol Sin. 2024 Oct.

. 2024 Oct;45(10):2226-2227.

doi: 10.1038/s41401-024-01271-2.

Authors

Affiliations

¹ The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, 100050, China.
² Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China.
³ Department of Neurosurgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, China.
⁴ Department of Clinical Laboratory, Peking Union Medical College Hospital, Beijing, 100730, China.
⁵ Department of Neurosurgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, China. ywang@pumch.cn.
⁶ The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, 100050, China. wjh@imm.ac.cn.
⁷ Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China. wjh@imm.ac.cn.

^# Contributed equally.

PMID: 38740905
PMCID: PMC11420235
DOI: 10.1038/s41401-024-01271-2

No abstract available

PubMed Disclaimer

Erratum for

Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis.
Zheng XJ, Chen WL, Yi J, Li W, Liu JY, Fu WQ, Ren LW, Li S, Ge BB, Yang YH, Zhang YZ, Yang H, Du GH, Wang Y, Wang JH. Zheng XJ, et al. Acta Pharmacol Sin. 2022 Nov;43(11):2977-2992. doi: 10.1038/s41401-022-00917-3. Epub 2022 May 17. Acta Pharmacol Sin. 2022. PMID: 35581292 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- PubMed Central

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis

Affiliations

Author Correction: Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources